Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Oscar Gerardo Arrieta Rodriguez"'
Autor:
Norma Hernández-Pedro, Masao Yamamoto-Ramos, Oscar Gerardo Arrieta Rodriguez, Pedro Barrios-Bernal, Mario Orozco-Morales, Francisco Lozano, Zyanya Lucia Zatarain-Barrón, Maritza Ramos, Diana Flores-Estrada, Diego López, Federico Maldonado, Christian Rolfo, Bernardo Cacho, Andres Felipe Cardona Zorrilla, Graciela Cruz-Rico
Publikováno v:
Journal of Clinical Oncology. 39:9114-9114
9114 Background: Hypoxia has been associated with chemo-radioresistance secondary to Vascular Endothelial Growth Factor Receptor induced by Hypoxia Induced Factor (HIF). Nitroglycerin (NTG) can reduce HIF-1 in cell lines, and this may have anti-angio
Autor:
Ingrid Vargas-Huicochea, Andrea Morales Morales Alfaro, Enrique Soto Perez De Celis, Andrea de la O Murillo, Pilar Bernal Pérez, Oscar Gerardo Arrieta Rodriguez, Asunción Álvarez del Río, Yanin Chavarri Guerra, Sofia Sánchez-Román, Diana Flores-Estrada, Daniela Ramirez Maza
Publikováno v:
Journal of Clinical Oncology. 39:e18827-e18827
e18827 Background: FT associated with cancer care damages patients’ quality of life and increases symptom burden. Developing countries lack public insurance programs to protect the growing population of older adults with cancer from catastrophic ex
Autor:
Oscar Gerardo Arrieta Rodriguez, Ángel Herrera Gómez, Edgardo Jiménez Fuentes, Luis Alberto Chinchilla Trigos
Publikováno v:
Gaceta Mexicana de Oncología. 15:350-357
ResumenEn el manejo de la enfermedad oncológica, la presentación de metástasis a pulmón se encuentra en el 20-60% a lo largo de su historia natural. Esta oscilación tan amplia obedece a la histología del tumor, comportamiento biológico, etapa
Autor:
Feliciano Barrón, Oscar Gerardo Arrieta Rodriguez, L. Cabrera, Andres Felipe Cardona Zorrilla
Publikováno v:
Journal of Clinical Oncology. 37:e18376-e18376
e18376 Background: Lung cancer is the leading cause of cancer-related mortality in México and worldwide. More than 80 percent of lung cancers are classified as non-small cell lung cancer (NSCLC). Immunotherapy has become integrated into the treatmen
Autor:
Andres Felipe Cardona Zorrilla, Feliciano Barrón, Oscar Gerardo Arrieta Rodriguez, Miguel-Ángel Salinas Padilla, Diana Flores-Estrada, Manuel Jiménez, Graciela Cruz-Rico, Laura Alejandra Ramírez-Tirado
Publikováno v:
Journal of Clinical Oncology. 36:9013-9013
9013Background: Metformin has been shown to have antitumor activity by increasing AMPK through different mechanisms involving tumor suppressor gene, LKB1. LKB1 inactivation is common in Non-small c...
Autor:
Josue Andres Gonzalez-Luna, Edgardo Jiménez-Fuentes, Miguel Patricio Moscoso-Fernandez Salvador, Raúl Alejandro López Saucedo, Oscar Gerardo Arrieta Rodriguez, Jose F. Corona-Cruz
Publikováno v:
Journal of Clinical Oncology. 36:e22193-e22193
e22193Background: MPE is a serious manifestation occurring in 10% of all cancer patients (ptes) and is associated with decreased survival (SV). Optimal window procedure has yet to be established, b...
Autor:
Amelia Insa, Rosario Garcia Campelo, Ana Drozdowskyj, Bartomeu Massuti, Reyes Bernabe Caro, Rafael Rosell, Ana Laura Ortega Granados, Ana Verdu, Joaquim Bosch-Barrera, Pilar Lianes, Sergio Vazquez-Estevez, Niki Karachaliou, M. Guirado, Noemi Reguart, David Vicente, Manuel Domine, Delvys Rodriguez-Abreu, Margarita Majem, Oscar Gerardo Arrieta Rodriguez, María Ángeles Sala
Publikováno v:
Journal of Clinical Oncology. 36:9012-9012
9012Background: Low BRCA1 mRNA levels correlate with longer progression free survival (PFS) in erlotinib treated EGFR mutant NSCLC patients (p), while risk of shortened PFS was associated with inte...
Autor:
Jose F. Corona-Cruz, Miguel Angel Jimenez-Rios, Miguel Patricio Moscoso-Fernandez Salvador, Edgardo Jiménez-Fuentes, Laura Alejandra Ramírez-Tirado, Miguel Álvarez, Raúl Alejandro López Saucedo, Josue Andres Gonzalez-Luna, Oscar Gerardo Arrieta Rodriguez
Publikováno v:
Journal of Clinical Oncology. 36:e16564-e16564
e16564Background: Reported 5-year SV for mRCC is about 10%. Introduction of inhibitors of VEGF and mTOR pathways have improved Progression Free Survival and Overall Survival (OS). High cost of new ...
Autor:
Horacio Noé López-Basave, Claudia Arce-Salinas, Oscar Gerardo Arrieta-Rodriguez, Jose Luis Aguilar-Ponce, Flavia Morales-Vásquez
Publikováno v:
Inflammatory Breast Cancer ISBN: 9780857299901
Systemic treatment with chemotherapy (CT) and other target therapies is the cornerstone in the treatment of the inflammatory breast cancer (IBC). Completeness a distinctive biological characterize and separate IBC from noninflammatory breast cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d31217f1b0e36e36aa1a8b2fa7eb3276
https://doi.org/10.1007/978-0-85729-991-8_10
https://doi.org/10.1007/978-0-85729-991-8_10
Autor:
Paula Juárez-Sánchez, Jaime G. de la Garza-Salazar, Horacio Astudillo-de la Vega, Oscar Gerardo Arrieta-Rodriguez, Erika Ruiz-García
Publikováno v:
Inflammatory Breast Cancer ISBN: 9780857299901
Inflammatory breast cancer (IBC) is a rare and clinically more aggressive type of breast cancer. This type of breast cancer is called “inflammatory” because the breast often appears to be swollen, reddened, or “inflamed.” Some studies have de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03787dcab360045898a0791732b18dc8
https://doi.org/10.1007/978-0-85729-991-8_9
https://doi.org/10.1007/978-0-85729-991-8_9